Oligometastatic Adenocarcinoma — Trials

Oligometastatic Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Azienda Ospedaliera Universitaria Integrata Verona
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04975516	Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer	terminated	Phase 2	2	Mayo ClinicOTHER	1	Jun 18, 2026	clinicaltrials
NCT07269626	PULSAR in Systemic Therapy for Pancreatic Cancer	recruiting	Phase 2	47	Samsung Medical CenterOTHER	1	Dec 8, 2025	clinicaltrials